Immunophotonics
MO - St. Louis
BiotechnologyFocus: Autologous cancer vaccine
Immunophotonics is a life sciences company focused on Autologous cancer vaccine.
OncologyInfectious DiseasesVaccines
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
IP-001
Colorectal CancerClinical Trials (1)
NCT06630624Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Phase 1/21.0% IP-001 for Injection
Metastatic Solid TumorClinical Trials (1)
NCT05688280Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Phase 1/2IP-001
Advanced Solid TumorsClinical Trials (1)
NCT03993678Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.
Phase 1/21.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water
Colorectal Cancer (CRC)Clinical Trials (1)
NCT07321847Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 4 clinical trials